Clinical Trial Update: Gametocytocidal and Transmission-blocking Efficacy of PQ in Combination With AL and TQ in Combination With SPAQ in Mali [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating gametocytocidal and transmission-blocking efficacy of PQ with AL and TQ with SPAQ in malaria patients in Mali; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falciparum Malaria
• Malaria

Drugs mentioned

• AL (artemisinin-based combination therapy)
• PQ (primaquine)
• SPAQ (sulfadoxine-pyrimethamine plus amodiaquine)
• TQ (tq‑compound)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria,Falciparum | Phase 2 | Status: COMPLETED